Advertisement

Topics

Cancer frim Repare Therapeutics announces $68m Series A financing

05:30 EDT 23 Jun 2017 | Pharmaceutical Business Review

Repare Therapeutics has secured $68m in a Series A financing round which it will use to advance its platform and pipeline of novel medicines that target genetically defined weaknesses of cancers.

Original Article: Cancer frim Repare Therapeutics announces $68m Series A financing

NEXT ARTICLE

More From BioPortfolio on "Cancer frim Repare Therapeutics announces $68m Series A financing"

Advertisement
Quick Search
Advertisement
Advertisement